Este artículo es originalmente publicado en:
, Baumhauer JF
, O’Keefe RJ
, Harrast J
, Hurwitz SR
, Voloshin I
Clin Orthop Relat Res.
2014 Nov;472(11):3510-6. doi: 10.1007/s11999-014-3823-3. Epub 2014 Aug 22.
Todos los derechos reservados para:
© The Association of Bone and Joint Surgeons® 2014
Primary glenohumeral osteoarthritis is a common indication for shoulder arthroplasty. Historically, both total shoulder arthroplasty (TSA) and hemi-shoulder arthroplasty (HSA) have been used to treat primary glenohumeral osteoarthritis. The choice between procedures is a topic of debate, with HSA proponents arguing that it is less invasive, faster, less expensive, and technically less demanding, with quality of life outcomes equivalent to those of TSA. More recent evidence suggests TSA is superior in terms of pain relief, function, ROM, strength, and patient satisfaction. We therefore investigated the practice of recently graduated orthopaedic surgeons pertaining to the surgical treatment of this disease.
The findings of this study are at odds with the recommendations in the current clinical practice guidelines for the treatment of glenohumeral osteoarthritis published by the American Academy of Orthopaedic Surgeons. These guidelines favor using TSA over HSA in the treatment of shoulder arthritis. Further investigation is needed to clarify if these practice patterns are isolated to recently graduated board eligible orthopaedic surgeons or if the use of HSA continues with orthopaedic surgeons applying for recertification.
LEVEL OF EVIDENCE:
Level III, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.